CENTRAL GARDEN & PET CO CENT
Central Garden & Pet Company ("Central") is a market leader in the U.S. pet and garden industries. For more than 40 years, we have delivered innovative, trusted solutions that help lawns grow greener, gardens bloom bigger, pets live healthier, and communities grow stronger. We operate through two reportable segments: Pet and Garden.
Our Pet segment offers a broad range of products for dog and cat supplies, including treats and chews, toys, beds and containment, grooming items, waste management and training pads. We also provide supplies for aquatics, small animals, reptiles and pet birds, such as toys, enclosures, habitats, bedding, food and supplements, equine and livestock products, animal and household health solutions and insect control items. This segment also includes live fish and small animals as well as outdoor cushions. Products are sold under well-recognized brands including Aqueon®, Best Bully Sticks®, Cadet®, C&S®, Comfort Zone®, Farnam®, Four Paws®, Kaytee®, Nylabone®, Zilla® and Zoëcon®.
Valuation FY2025 figures against the last close
Annual financial statements
Income statement
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | $3.13B | $3.20B | $3.31B | $3.34B | $3.30B | $2.70B | $2.38B | $2.22B | $2.05B | $1.83B |
| Cost of revenue | $2.13B | $2.26B | $2.36B | $2.35B | $2.33B | $1.90B | $1.68B | $1.54B | $1.42B | $1.28B |
| Gross profit | $997.3M | $943.7M | $946.8M | $992.3M | $970.9M | $796.6M | $704.0M | $675.4M | $632.8M | $553.0M |
| SG&A | $747.3M | $758.3M | $736.2M | $732.3M | $716.4M | $598.6M | $552.0M | $508.0M | $476.7M | $421.9M |
| Operating income | $250.0M | $185.4M | $210.6M | $260.0M | $254.5M | $198.0M | $152.1M | $167.3M | $156.1M | $129.4M |
| Interest expense | $57.7M | $57.5M | $57.0M | $58.3M | $58.6M | $44.0M | $42.6M | $39.2M | $28.2M | $42.8M |
| Pre-tax income | $216.8M | $142.4M | $162.4M | $198.9M | $194.8M | $153.7M | $119.3M | $127.4M | $126.4M | $69.6M |
| Income tax | $52.8M | $33.1M | $36.3M | $46.2M | $42.0M | $32.2M | $26.6M | $3.3M | $46.7M | $24.1M |
| Net income | $162.8M | $108.0M | $125.6M | $152.2M | $151.7M | $120.7M | $92.8M | $123.6M | $78.8M | $44.5M |
| EPS, basic | 2.58 | 1.64 | 1.92 | 2.29 | 2.81 | 2.23 | 1.63 | 2.39 | 1.57 | 0.91 |
| EPS, diluted | 2.55 | 1.62 | 1.88 | 2.24 | 2.75 | 2.20 | 1.61 | 2.32 | 1.52 | 0.87 |
| Shares, diluted (wtd. avg.) | $63.8M | $66.9M | $66.8M | $68.0M | $55.2M | $54.7M | $57.6M | $53.3M | $51.8M | $51.1M |
Balance sheet
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash and equivalents | $882.5M | $753.5M | $488.7M | $192.2M | $439.5M | $666.4M | $510.7M | $493.0M | $45.0M | $103.9M |
| Receivables | $325.3M | $326.2M | $332.9M | $376.8M | $385.4M | $391.8M | $300.1M | $275.9M | $237.9M | $201.2M |
| Inventory | $722.1M | $757.9M | $838.2M | $938.0M | $685.2M | $439.6M | $466.2M | $427.8M | $382.1M | $362.0M |
| Total current assets | $1.98B | $1.89B | $1.71B | $1.55B | $1.54B | $1.53B | $1.31B | $1.22B | $683.1M | $683.3M |
| Property, plant and equipment | $363.2M | $379.2M | $391.8M | $397.0M | $328.6M | $244.7M | $245.4M | $217.6M | $180.9M | $158.2M |
| Goodwill | $554.7M | $551.4M | $546.4M | $546.4M | $369.4M | $290.0M | $286.1M | $281.2M | $256.3M | $231.4M |
| Other intangibles | $447.6M | $473.3M | $497.2M | $543.2M | $134.4M | $134.9M | $146.1M | $152.3M | $116.1M | $95.9M |
| Total assets | $3.63B | $3.55B | $3.38B | $3.28B | $3.12B | $2.34B | $2.03B | $1.91B | $1.31B | $1.18B |
| Accounts payable | $234.6M | $212.6M | $190.9M | $215.7M | $245.5M | $205.2M | $149.2M | $110.3M | $103.3M | $102.4M |
| Short-term debt | $62.0K | $239.0K | $247.0K | $317.0K | $1.1M | $97.0K | $113.0K | $122.0K | $375.0K | $463.0K |
| Total current liabilities | $538.8M | $515.4M | $458.0M | $465.9M | $522.3M | $440.3M | $278.5M | $213.0M | $220.2M | $202.2M |
| Long-term debt | $1.19B | $1.19B | $1.19B | $1.19B | $1.18B | $694.0M | $693.0M | $692.0M | $395.3M | $394.8M |
| Retained earnings | $1.02B | $959.5M | $859.4M | $755.3M | $646.1M | $510.8M | $421.7M | $362.9M | $239.3M | $160.5M |
| Total equity | $1.58B | $1.56B | $1.45B | $1.33B | $1.22B | $1.08B | $996.2M | $952.8M | $637.1M | $554.6M |
Cash flow
| Fiscal year | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 |
|---|---|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $332.5M | $394.9M | $381.6M | -$34.0M | $250.8M | $264.3M | $205.0M | $114.1M | $114.3M | $151.4M |
| Depreciation and amortisation | $84.9M | $90.8M | $87.7M | $80.9M | $74.7M | $55.4M | $50.8M | $47.2M | $42.7M | $40.0M |
| Stock-based compensation | $21.1M | $20.6M | $28.0M | $25.8M | $23.1M | $19.0M | $14.7M | $11.6M | $11.1M | $8.4M |
| Capital expenditure | $41.4M | $43.1M | $54.0M | $115.2M | $80.3M | $43.1M | $31.6M | $37.8M | $44.7M | $27.6M |
| Investing cash flow | -$44.9M | -$105.2M | -$34.6M | -$143.0M | -$899.4M | -$48.1M | -$76.3M | -$140.9M | -$162.8M | -$91.2M |
| Financing cash flow | -$156.6M | -$25.4M | -$37.6M | -$66.8M | $420.5M | -$60.6M | -$110.8M | $474.8M | -$10.4M | -$14.2M |
| Buybacks | $155.1M | $24.1M | $37.2M | $62.3M | $27.9M | $59.1M | $63.0M | $13.8M | $27.6M | $10.9M |
Figures as tagged in each year's own filing, in US dollars. A year restated by a later filing shows the restated figure. Capital expenditure, dividends and buybacks are cash out, shown positive. A line the filer does not report is not listed. Latest from accession 0000887733-25-000041.
Others in SIC 5190
| Ticker | Company | Market cap | P/E | Revenue growth |
|---|---|---|---|---|
| VSTS | Vestis Corp | $1.75B | — | -2.5% |
| NHTC | NATURAL HEALTH TRENDS CORP | $13.6M | — | -7.4% |
| EDUC | EDUCATIONAL DEVELOPMENT CORP | $11.5M | 5.0x | -33.0% |
| HYFM | HYDROFARM HOLDINGS GROUP, INC. | $4.6M | — | -29.4% |